Skip to main content
Toggle navigation
Login
Search
Home
Tweets by RAPS Euro Convergence 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
D
Da Rocha Dias , Silvy
European Medicines Agency
Conversations That Matter: Interactions with Health Authorities
Location: Pearl 1 + 2 + 3
Silvy Da Rocha Dias
Favorite
Expert Advisory Panel - What Have we Learned?
Location: Pearl 1
Silvy Da Rocha Dias
Favorite
Datri, Fabio
European Commission
Will the Revision of the EU general pharmaceuticals legislation deliver a world-class, future-proof medicines regulatory system for Europe? (Part 1)
Location: Pearl 1
Fabio Datri
Favorite
Will the Revision of the EU general pharmaceuticals legislation deliver a world-class, future-proof medicines regulatory system for Europe?(Part 2 )
Location: Pearl 1
Fabio Datri
Favorite
Dawley, Ashleigh
Integrated DNA Technologies, Inc., a Danaher Company
Research Use Only (RUO): What does this mean for legacy devices and product development of new in vitro diagnostics under the IVDR?
Location: Pearl 1
Ashleigh Dawley
Favorite
Day, Francesca
European Medicines Agency
Will the Revision of the EU general pharmaceuticals legislation deliver a world-class, future-proof medicines regulatory system for Europe? (Part 1)
Location: Pearl 1
Francesca Day
Favorite
Will the Revision of the EU general pharmaceuticals legislation deliver a world-class, future-proof medicines regulatory system for Europe?(Part 2 )
Location: Pearl 1
Francesca Day
Favorite
de Azevedo Wäsch, Susana
Ypsomed
Due Diligence: Critical Importance of Regulatory & Quality to Support Company or Product Acquisitions
Location: Pearl 3
Susana de Azevedo Wäsch
Favorite
Responsibilities and Liabilities in an Interconnected World
Location: Pearl 2
Susana de Azevedo Wäsch
Favorite
Traceability of devices; the administrative burden or a smart set-up for legal manufacturers?
Location: Pearl 3
Susana de Azevedo Wäsch
Favorite
de Vries, Corinne
European Medicines Agency
Strategic approaches in pregnancy and paediatrics: Is it time for a paradigm shift?
Location: Pearl 1
Corinne de Vries
Favorite
Dequeker, Elisabeth
University of Leuven
Conformity Assessment of Class D Devices: What is the Current Status?
Location: Pearl 2
Elisabeth Dequeker
Favorite
Dequeker, Elisabeth
Prof
IVDR – what are the implications for in-house in vitro devices for stakeholders and practical steps for implementation
Location: Carmine & Charcoal
Elisabeth Dequeker
Favorite
Di Rienzo, Giovanni
Qserve Group
Clinical assessment: how to minimize the questions from your Notified Body
Location: Pearl 2
Giovanni Di Rienzo
Favorite
Device Lifetime and Lifecycle Management
Location: Pearl 3
Giovanni Di Rienzo
Favorite
UKCA: challenges and opportunities
Location: Pearl 3
Giovanni Di Rienzo
Favorite
